Cargando…

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

Bone marrow niches support multiple myeloma, providing signals and cell-cell interactions essential for disease progression. A 3D bone marrow niche model was developed, in which supportive multipotent mesenchymal stromal cells and their osteogenic derivatives were co-cultured with endothelial progen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braham, Maaike V. J., Minnema, Monique C., Aarts, Tineke, Sebestyen, Zsolt, Straetemans, Trudy, Vyborova, Anna, Kuball, Jurgen, Öner, F. Cumhur, Robin, Catherine, Alblas, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980416/ https://www.ncbi.nlm.nih.gov/pubmed/29872571 http://dx.doi.org/10.1080/2162402X.2018.1434465

Ejemplares similares

Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma
por: Braham, Maaike VJ, et al.
Publicado: (2018)

The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges
por: Janssen, Anke, et al.
Publicado: (2022)

Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
por: Johanna, Inez, et al.
Publicado: (2019)

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults
por: Vyborova, Anna, et al.
Publicado: (2022)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
por: van Diest, Eline, et al.
Publicado: (2021)

Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells
por: Kierkels, Guido J.J., et al.
Publicado: (2021)

Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control
por: Johanna, Inez, et al.
Publicado: (2021)

Bone marrow niche in multiple myeloma and its precursor states
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2019)

Serpin B9 controls tumor cell killing by CAR T cells
por: Kimman, Thomas, et al.
Publicado: (2023)

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018)

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
por: de Witte, Moniek A., et al.
Publicado: (2015)

The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis
por: Capp, Jean-Pascal, et al.
Publicado: (2023)

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
por: Meringa, A. D., et al.
Publicado: (2023)

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
por: Drent, Esther, et al.
Publicado: (2015)

Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells
por: Nair, Jayakumar R., et al.
Publicado: (2012)

Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches
por: Wong, David, et al.
Publicado: (2014)

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche
por: Müller, Louise M E, et al.
Publicado: (2021)

Niche-modulated and niche-modulating genes in bone marrow cells
por: Cohen, Y, et al.
Publicado: (2012)

Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
por: Colombo, Michela, et al.
Publicado: (2016)

Microfluidic device engineered to study the trafficking of multiple myeloma cancer cells through the sinusoidal niche of bone marrow
por: Sui, Chao, et al.
Publicado: (2022)

EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression
por: Ling, Wen, et al.
Publicado: (2023)

Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis
por: van Nieuwenhuijzen, Niels, et al.
Publicado: (2021)

The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma
por: Saka, Bülent, et al.
Publicado: (2019)

Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment
por: Croes, Michiel, et al.
Publicado: (2015)

Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-Immunomodulation
por: Khokhani, Paree, et al.
Publicado: (2021)

Modulation of Bone and Marrow Niche by Cholesterol
por: Yin, Wenzhen, et al.
Publicado: (2019)

Regulation of the Bone Marrow Niche by Inflammation
por: Mitroulis, Ioannis, et al.
Publicado: (2020)

Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019)

Bone marrow niches in myelodysplastic syndromes
por: Tosato, Giovanna, et al.
Publicado: (2021)

The Hematopoietic Bone Marrow Niche Ecosystem
por: Fröbel, Julia, et al.
Publicado: (2021)

Bioengineering the Bone Marrow Vascular Niche
por: Bessy, Thomas, et al.
Publicado: (2021)

Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
por: Welters, Carlotta, et al.
Publicado: (2022)

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients
por: Oostvogels, Rimke, et al.
Publicado: (2018)

Expanded microbiome niches of RAG-deficient patients
por: Blaustein, Ryan A., et al.
Publicado: (2023)

Actors on the Scene: Immune Cells in the Myeloma Niche
por: Leone, Patrizia, et al.
Publicado: (2020)

Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
por: Holthof, Lisa C., et al.
Publicado: (2020)

Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition
por: Sánchez‐Lanzas, Raúl, et al.
Publicado: (2022)

A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications
por: Jakubikova, Jana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ofh1mh5vn5u4i1gddjqjij16pm